Premium
Pharmacodynamic interaction studies of Ginkgo biloba with cilostazol and clopidogrel in healthy human subjects
Author(s) -
Aruna D.,
Naidu M. U. R.
Publication year - 2007
Publication title -
british journal of clinical pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.216
H-Index - 146
eISSN - 1365-2125
pISSN - 0306-5251
DOI - 10.1111/j.1365-2125.2006.02759.x
Subject(s) - cilostazol , ginkgo biloba , clopidogrel , pharmacology , antiplatelet drug , medicine , bleeding time , crossover study , pharmacodynamics , platelet , aspirin , platelet aggregation , pharmacokinetics , alternative medicine , pathology , placebo
Aims Ginkgo biloba is available as an over‐the‐counter drug and reported to cause haemorrhage when coadministered with other antiplatelet agents. We set out to study the interactions of G. biloba with cilostazol and clopidogrel. Methods A randomized, open‐label, crossover study of 10 healthy male volunteers. The dosage schedules were 120 mg G. biloba , 240 mg G. biloba , 100 mg cilostazol, 200 mg cilostazol, 75 mg clopidogrel, 150 mg clopidogrel, 120 mg G. biloba + 100 mg cilostazol and 120 mg G. biloba + 75 mg clopidogrel. Platelet aggregation, platelet count, bleeding time and clotting time were measured 0 and 6 h after drug administration. Platelet aggregation was performed using a dual channel aggregometer, by the turbimetric technique using adenosine diphosphate 5 µmol and 10 µmol, and collagen 1 µg ml −1 . Results Platelet inhibition with the combination of G. biloba and clopidogrel or cilostazol was not statistically significant compared with individual doses of drugs, with all the three aggregants. There was significant ( P < 0.05) potentiation of prolongation of bleeding time with the combination of cilostazol and G. biloba compared with individual doses of both the drugs. There was no significant change in clotting time and platelet count. Conclusions Coadministration of G. biloba either with cilostazol or clopidogrel did not enhance antiplatelet activity compared with individual agents. Ginkgo biloba potentiated the bleeding time prolongation effect of cilostazol. There was no significant correlation between prolongation of bleeding time and inhibition of platelet aggregation.